DiA Imaging Analysis(formerly Dia Cardio)

The company focuses on the health tech market, specifically developing AI-powered software to automate the analysis of ultrasound images. This technology addresses two primary challenges in sonography: the consistent capture of high-quality images and the objective analysis of those images. DiA's solutions cater to clinicians with varying levels of ultrasound experience, aiming to reduce subjectivity and improve efficiency and accuracy in diagnoses. The business model involves partnerships and integrations with leading ultrasound device manufacturers and healthcare IT system providers, such as GE Healthcare, Konica Minolta, and IBM Watson. This vendor-neutral approach allows their software to function across different platforms.

DiA's core product is the LVivo AI-based software line, which has received multiple FDA clearances and CE marks. This software suite uses advanced pattern recognition and deep learning algorithms to mimic how the human eye detects borders and motion, thereby automating the analysis of cardiac and abdominal ultrasound images. A key offering, LVivo Seamless, runs in the background to automatically select the best cardiac views from an exam and generates key measurements like Ejection Fraction (EF) and Global Longitudinal Strain (GLS). Another solution, LVivo IQS, provides real-time feedback to the user during the scanning process to ensure high-quality images are captured. Before its acquisition, the company had raised a total of $25 million and served thousands of users in over 20 countries.